Images in Clinical Medicine: Massive Splenomegaly¶
Summary¶
- 35yo M
- c/c
- 3w Hx of
- fatigue
- painful distention of Lt side of abd
- 3w Hx of
- PMH
- hepatosplenic T-cell lymphoma
- PEx
- massive enlargement of liver & spleen
- Ex
- CT
- hepatomegaly
- splenomegaly
- L/D
- ↑WBC 17400/mm3 (4000-11000)
- ↓Hb 3.9g/dL (13.3-17.7)
- ↓Plt 10000/mm3 (150000-450000)
- smear
- atypical mononuclear
- intermediate to large in size
- irreg nuc contours
- moderatorely fine chromatin
- prominent nucleoli
- cytoplasmic blebs
- atypical mononuclear
- flowcytometry
- relapse hepatosplenic T-cell lymphoma
- CT
- DDx
- massive splenomegaly
- chronic myeloid leukemia
- myelofibrosis
- hairy-cell leukemia
- malaria, β-thalassemia major
- visceral leishmaniasis
- massive splenomegaly
- Tx
- immune checkpoint blockade
- opioid analegesics
- Progress
- presentation +10w died
Further¶
Terminology¶
Original¶
A 35-year-old man presented to the emergency department with a 3-week history of fatigue and painful distention of the left side of his abdomen. He had a history of hepatosplenic T-cell lymphoma and had completed treatment 9 months earlier. Physical examination revealed massive enlargement of the liver and spleen, with the spleen crossing the midline and its lower margin extending into the pelvis. A computed tomographic scan of the abdomen confirmed hepatomegaly and splenomegaly (with the spleen measuring 36 cm in its greatest dimension). The white-cell count was 17,400 per cubic millimeter (reference range, 4000 to 11,000), the hemoglobin level 3.9 g per deciliter (reference range, 13.3 to 17.7), and the platelet count 10,000 per cubic millimeter (reference range, 150,000 to 450,000). A blood smear showed atypical mononuclear cells, intermediate to large in size, with irregular nuclear contours, moderately fine chromatin, prominent nucleoli, and some cytoplasmic blebs. Relapsed hepatosplenic T-cell lymphoma was confirmed on flow cytometry. Other causes of massive splenomegaly include chronic myeloid leukemia, myelofibrosis, hairy-cell leukemia, malaria, β-thalassemia major, and visceral leishmaniasis. Treatment with immune checkpoint blockade and opioid analgesics was initiated, but the patient died consequent to disease progression 10 weeks after presentation.